- Home
- CROX vs NOVT Comparison
CROX vs NOVT Comparison
Compare CROX & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CROX | NOVT |
|---|---|---|
| Founded | 1999 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | CROX | NOVT |
|---|---|---|
| Price | $84.13 | $134.45 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $91.60 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 1.0M | 456.9K |
| Earning Date | 02-12-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.26 | 1.46 |
| Revenue | ★ $4,072,780,000.00 | $960,311,000.00 |
| Revenue This Year | N/A | $5.07 |
| Revenue Next Year | N/A | $6.68 |
| P/E Ratio | ★ $26.60 | $93.64 |
| Revenue Growth | 0.01 | ★ 4.07 |
| 52 Week Low | $73.21 | $98.27 |
| 52 Week High | $122.84 | $153.20 |
Technical Indicators
Market Signals| Indicator | CROX | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 46.45 | 54.92 |
| Support Level | $83.06 | $133.16 |
| Resistance Level | $88.50 | $143.02 |
| Average True Range (ATR) | 2.66 | 5.39 |
| MACD | 0.17 | -0.74 |
| Stochastic Oscillator | 40.13 | 35.32 |
Price Performance
Historical ComparisonAbout CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.